Search images on Google      Product Monograph

Active Ingredients:

• antihemophilic factor viii (recombinant, b-domain truncated), pegylated, 1000 UNIT/VIAL

DIN: 02490072

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Schedule D

Company: NOVO NORDISK CANADA INC  –  official site

ATC:

• B02 - ANTIHEMORRHAGICS (ATC, WHO, Wiki)
• B02B - VITAMIN K AND OTHER HEMOSTATICS (ATC, WHO)
• B02BD - Blood coagulation factors (ATC, WHO)
• B02BD02 - COAGULATION FACTOR VIII (WHO)

Reference brand drug:

Pharmaceutical standard: MFR

 

External Links for Esperoct:

Search on Google

• Esperoct side effects
• Esperoct dosage
• antihemophilic factor viii side effects
• antihemophilic factor viii dosage

Novo Nordisk Canada Inc

Go to Novo Nordisk website to see drug product details. Sometimes you can find esperoct photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.